Source: Livemint

Cenexi: Gland Pharma's European acquisition to enhance reach, offerings

Given that Cenexi has capabilities in processing substances such as hormones, suspensions, and controlled substances, it would expand Gland Pharma's overall offerings to its customers

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
1.0-5.0K
Christophe Durand's photo - CEO of Cenexi

CEO

Christophe Durand

CEO Approval Rating

90/100

Read more